Cisplatin and 5-fluorouracil
WebJul 14, 2024 · Fluorouracil (5FU) is a type of chemotherapy drug. It’s typically used in combination with other cancer drugs to treat several different types of cancer, including: … WebSakai M, Sohda M, Saito H, et al. Concurrent Chemoradiotherapy with docetaxel, cisplatin, and 5‐fluorouracil (DCF‐RT) vs. cisplatin and 5‐fluorouracil (CF‐RT) for patients with …
Cisplatin and 5-fluorouracil
Did you know?
WebChemotherapy regimens included 5-fluorouracil (5-FU) in combination with interferon (n = 2 from Japan), cisplatin alone or in combination with 5-FU and other drugs (n = 4 from Japan and n = 1 from Korea), 5-FU and oxaliplatin (n = 2 from China), and 5-FU, cisplatin, leucovorin, and epirubicin (n = 1 from China). The OS ranged from 33.2 to 56.4 ...
WebSelect search scope, currently: articles+ all catalog, articles, website, & more in one search; catalog books, media & more in the Stanford Libraries' collections; articles+ journal articles & other e-resources WebFeb 27, 2024 · Clavel M, Vermorken JB, Cognetti F, et al. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer …
WebKish JA, Weaver A, Jacobs J, Cumminp G. AISarraf M. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 1984; 53: 18 19-1 824. 15. Kish J, Drelichman A, Jacobs J er al. Clinical trial of cis-platinum and 5-fluorouracil infusion as initial treatment of advanced squamous WebDec 19, 2011 · The platinum-based chemotherapy agents cisplatin, carboplatin, and oxaliplatin, used to treat a huge number of cancers including the lung, upper and lower GI, ovarian, and germ cell tumours, are a common cause of renal tubular and glomerular damage, which can be treatment-limiting.
WebApr 1, 2024 · [Show full abstract] fluorouracil(1000mg per square meter of body-surface area daily for 5 days) and cisplatin(60mg per square meter on the first day)(D1 and D29) plus 48Gy of radiation therapy(RT ...
WebCisplatin, fluorouracil (5-FU) and trastuzumab is a combination of cancer drugs. Cisplatin and fluorouracil are chemotherapy drugs, and trastuzumab (Herceptin) is a targeted … hidden valley community centreWebMay 20, 2024 · Investigators decided to associate radiotherapy, PD-1 (Programmed cell Death-1) inhibitor and mDCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy regimen to improve the efficacy with higher rate of long-lasting progression-free survivors and complete remissions. hidden valley chuck roastWebJan 8, 2024 · Purpose To determine the efficacy and toxicity of two standard chemotherapy regimens used concurrent with radiation for the treatment of esophageal cancer: cisplatin/5-fluorouracil (5-FU) and carboplatin/paclitaxel. Materials and methods We prospectively reviewed records of 364 patients with histolo … hidden valley clock towerWebSakai M, Sohda M, Saito H, et al. Concurrent Chemoradiotherapy with docetaxel, cisplatin, and 5‐fluorouracil (DCF‐RT) vs. cisplatin and 5‐fluorouracil (CF‐RT) for patients with Unresectable locally advanced esophageal cancer in a real‐world clinical setting. Anticancer Res. 2024; 41:2141‐2145. [Google Scholar] hidden valley country club dress codeWebDec 15, 2016 · Duligotuzumab in combination with cisplatin/5-fluorouracil or carboplatin/paclitaxel demonstrated encouraging activity in patients with … howell high school football fieldWebMar 5, 2024 · When this trial was initiated in 2014, the EXTREME regimen (platinum, fluorouracil, and cetuximab followed by weekly 250 mg/m 2 cetuximab maintenance) was considered the first-line standard treatment option in patients with recurrent or metastatic head and neck squamous-cell carcinoma (HNSCC) not suitable for locoregional curative … howell high school farmingdale nj basketballWebJan 22, 2024 · In summary, the first innovative aspect of this research program is to provide a valuable proof of concept study evaluating the feasibility to combine radiotherapy, chemotherapies (docetaxel, cisplatin and 5-fluorouracil) and Ezabenlimab (BI 754091) in patients with stage III squamous cell anal carcinoma. hidden valley community association